ATC Group: V08CA03 Gadodiamide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08CA03 in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08C Magnetic resonance imaging contrast media
4 V08CA Paramagnetic contrast media
5 V08CA03 Gadodiamide

Active ingredients in V08CA03

Active Ingredient Description
Gadodiamide

Gadodiamide is a paramagnetic contrast agent (GBCA), with imaging activity upon magnetic resonance imaging (MRI). Gadodiamide activity enhances the visualization of the tissues.

Medicines in this ATC group

United States (US)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

Hong Kong (HK)

Japan (JP)

Lithuania (LT)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.